What’s Next for Pharma?
Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, mergers, and the FDA’s changing role
What’s Next for Pharma?
Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, mergers, and the FDA’s changing role